Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Long-Term Safety Extension Study of CHS-0214 in Rheumatoid Arthritis
jRCT2080222875Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2015
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of GP2015 in rheumatoid arthritis (RA), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
GP2015
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2080222875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222875.